Prospective, open-label, multicentre study on the incidence of Squamous Cell Carcinoma and Actinic Keratoses in solid organ transplant recipients treated with per protocol, cyclic field application of MAL-PDT versus lesion adapted cryotherapy [Prospektive Multicenterstudie zur Behandlung und Prophylaxe von aktinischen Keratosen und Plattenepithelkarzinomen bei organtransplantierten Patienten mittels zyklischer Feldbehandlung durch MAL-PDT versus läsionsgerichteter Therapie mit Kryotherapie].

Trial Profile

Prospective, open-label, multicentre study on the incidence of Squamous Cell Carcinoma and Actinic Keratoses in solid organ transplant recipients treated with per protocol, cyclic field application of MAL-PDT versus lesion adapted cryotherapy [Prospektive Multicenterstudie zur Behandlung und Prophylaxe von aktinischen Keratosen und Plattenepithelkarzinomen bei organtransplantierten Patienten mittels zyklischer Feldbehandlung durch MAL-PDT versus läsionsgerichteter Therapie mit Kryotherapie].

Discontinued
Phase of Trial: Phase III

Latest Information Update: 12 Aug 2014

At a glance

  • Drugs Methyl aminolevulinate (Primary)
  • Indications Actinic keratosis; Squamous cell cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Aug 2014 According to the European Clinical Trials Database record, status changed from recruiting to discontinued.
    • 29 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top